Valley National Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Valley National Bancorp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$7K	Buy	+124	New	+$6.99K	0.01%	174

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Valley National Bancorp's BMY Position: Q4 2014 in Review

Valley National Bancorp opened a new position in Bristol-Myers Squibb (BMY) in Q4 2014: 124 shares worth $7K. The stake represents 0.01% of the portfolio and ranks #174 among its holdings.

1,411 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

Valley National Bancorp held 124 shares of Bristol-Myers Squibb worth $7K as of Q4 2014.
Bristol-Myers Squibb was a new Valley National Bancorp position in Q4 2014.
Bristol-Myers Squibb made up 0.01% of Valley National Bancorp's portfolio in Q4 2014, its #174 holding.
1,411 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Valley National Bancorp's 13F filing for Q4 2014, filed 9 Feb 2015.